CD274 and glioblastoma: In glioblastoma, PD-L1 antibodies have been shown to enhance macrophage phagocytic activity by activating the ERK pathway (68) and to promote macrophage proliferation, survival, and activation, such as through the expression of the co-stimulatory molecules CD86 and MHC II (69).